NCT01041287
Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells
See it on ClinicalTrials.gov ↗30 people
43.3%
56.7%
13 womenmiddle line = equal numbers17 men
- Phase
- PHASE4
- Paid for by
- Emory University
- Finished
- 2013-12
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 21 Years – 80 Years
- Average age
- Not reported
- Age 65+
- 6.7%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Premenopausal females with potential for pregnancy”
- Only women past menopause
Women who could still get pregnant were turned away.
“Males or post-menopausal females aged 21-80 years.”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Chronic renal failure \[creatinine \> 2.5 mg/dL\] or liver failure (Liver enzymes \>2X normal)”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Acute coronary syndrome, Class IV heart failure, CVA, coronary intervention within 2 months”
- No cancer
Women with current or past cancer were turned away.
“Current neoplasm”
Study titles and rules are shown in their original English.